Skip to main content
  • Real-World US TAVR Outcomes Similar to RCTs in First Study to Estimate Standard Practice Treatment Effects

    Real-world outcomes for transcatheter aortic valve replacement (TAVR) patients are likely similar to those observed in randomized controlled trials (RCTs), despite some key differences in important baseline characteristics between those treated in trial and clinic, researchers comparing U.S. CoreValve trial results with Medicare data said.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details